[HTML][HTML] Apixaban with antiplatelet therapy after acute coronary syndrome
Background Apixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent
ischemic events when added to antiplatelet therapy after an acute coronary syndrome …
ischemic events when added to antiplatelet therapy after an acute coronary syndrome …
[HTML][HTML] Prevention of bleeding in patients with atrial fibrillation undergoing PCI
Background In patients with atrial fibrillation undergoing percutaneous coronary intervention
(PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus …
(PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus …
Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry
JW Van Werkum, AA Heestermans, AC Zomer… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to comprehensively identify predictors of stent thrombosis (ST).
Background: Given the devastating consequences of ST, efforts should be directed toward …
Background: Given the devastating consequences of ST, efforts should be directed toward …
Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study …
A Meijer, FW Verheugt, CJ Werter, KI Lie… - Circulation, 1993 - Am Heart Assoc
BACKGROUND Successful coronary thrombolysis involves a risk for reocclusion that cannot
be prevented by invasive strategies. Therefore, we studied the effects of three antithrombotic …
be prevented by invasive strategies. Therefore, we studied the effects of three antithrombotic …
A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients.
P Vranckx, FW Verheugt, MP de Maat… - … : journal of EuroPCR …, 2013 - europepmc.org
Aims Patients receiving long-term anticoagulant treatment with dabigatran may need to
undergo a percutaneous coronary intervention (PCI). We studied markers of coagulation …
undergo a percutaneous coronary intervention (PCI). We studied markers of coagulation …
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
F Vermeer, ML Simoons, FW Bär, JG Tijssen… - Circulation, 1986 - Am Heart Assoc
The effect of thrombolysis in acute myocardial infarction on enzymatic infarct size, left
ventricular function, and early mortality was studied in subsets of patients in a randomized …
ventricular function, and early mortality was studied in subsets of patients in a randomized …
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from …
WJ Dewilde, PW Janssen, JC Kelder… - … : Journal of Europcr in …, 2015 - europepmc.org
Aims To investigate the optimal periprocedural antithrombotic strategy in patients on long-
term oral anticoagulation (OAC) who require percutaneous coronary intervention with …
term oral anticoagulation (OAC) who require percutaneous coronary intervention with …
Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo …
FW Bär, FW Verheugt, J Col, P Materne, JP Monassier… - Circulation, 1992 - Am Heart Assoc
BACKGROUND The value of thrombolytic therapy in unstable angina is unclear. METHODS
AND RESULTS To study this problem, 159 patients were studied in a double-blind, placebo …
AND RESULTS To study this problem, 159 patients were studied in a double-blind, placebo …
Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass …
L Noyez, I Plesiewicz, FW Verheugt - European Journal of Cardio …, 2006 - europepmc.org
Background Preoperative renal failure is a risk factor for adverse events in cardiac surgery.
Serum creatinine (SCr) is the most used test for renal failure. However, patients can have …
Serum creatinine (SCr) is the most used test for renal failure. However, patients can have …
Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.
A Meijer, FW Verheugt, MJ Van Eenige, CJ Werter - Circulation, 1994 - Am Heart Assoc
BACKGROUND After successful thrombolysis for acute myocardial infarction, reocclusion is
observed in about 30% of patients after 3 months and usually occurs without reinfarction. We …
observed in about 30% of patients after 3 months and usually occurs without reinfarction. We …